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The Effect of Leucine Supplementation on Mitochondrial Biogenesis and
Mitochondrial Protein Synthesis in Rats Fed a High-Fat Diet
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Abstract
This study aims to illuminate interaction between leucine supplementation and mitochondrial proteins
concerned with synthesis and biogenesis. We hypothesized that supplementation with leucine will
attenuate the weight gain of the high fat diet in comparison with the normal chow group, by enhancing
mitochondrial biogenesis and content. We conducted a laboratory experiment using Western Blotting
techniques to determine protein expression. Proteins of interest in this study include PGC-1α, COX-IV,
TUFM, TFAM, and mtIF2. The findings from the research show a main effect of an increase in the
expression of PGC-1 α in high fat diets. There was no difference in the expression of COX-IV with regard
to either leucine supplementation or diet. There was a main effect of an increase in the expression of
TUFM in high fat diets. A main effect of an increase in mtIF2 was seen in NC groups when compared with
HF diet groups. The findings of this study support the current model that high fat diets cause
dysregulation of mitochondria in that PGC-1 α protein content was upregulated and yet COX-IV protein
content was unchanged.
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1. Introduction
Obesity is a metabolic disease defined as having a body mass index greater than or equal to 30
kg/m². Obesity is associated with various comorbidities such as type 2 diabetes, gall bladder disease,
high blood pressure, and osteoarthritis (Must et al., 1999).There has also been an increase in the
occurrence of obesity surrounding the turn of the 21st century (Baskin, Ard, Franklin, & Allison, 2005).
This increase in obesity has been shown to be the result of increased amounts of food intake along with
decreases in physical activity (Wing et al., 2001). Obesity is also associated with an increase in
intramuscular triglycerides, and this has been associated with insulin resistance, lipotoxicity, and
incomplete β-oxidation in muscle (Holloway, Bonen, & Spriet, 2009). Obesity is a rapidly growing
metabolic disease that is deteriorating the quality of life of millions of people.
Mitochondria supply the body and more specifically skeletal muscle with the ability to undergo
aerobic metabolism in the form of oxidative phosphorylation. Skeletal muscle uses this organelle as a
means of synthesizing the energetic substrate ATP (Ernster & Schatz, 1981). In addition to this function,
the electron transport chain, intracellular calcium regulation, fatty acid oxidation, and regulation of
apoptosis, all occur within the mitochondria of skeletal muscle (Green & Reed, 1998; Kennedy &
Lehninger, 1949; Vasington & Murphy, 1962). Recent studies suggest that obesity impairs mitochondrial
quantity and oxidative capacity (Chanséaume & Morio, 2009). Impairment in oxidative capacity has
been linked to increases in fatty acid accumulation within skeletal muscle. Additionally, during a high-fat
diet, mitochondrial protein synthesis is disrupted as evidenced by decreased cytochrome c oxidase
activity and inhibited mitochondrial respiration (Greene et al., 2014). Another detriment to oxidative
capacity comes in the form of impaired mitochondrial biogenesis. Mitochondrial biogenesis is the
process by which new mitochondria are created. PGC-1α, the master regulator of mitochondrial
biogenesis, is decreased due to high fat diets, obesity, and lipid infusion (Greene et al., 2014; Richardson
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et al., 2005; Sparks et al., 2005). These impairments to mitochondrial function then lead to decreased
quality of life from cardiovascular disease, diabetes, and weight gain.
Mitochondrial protein synthesis includes transcription, the process by which mRNA transcript is
synthesized from DNA. Then, in translation, the mRNA transcript is brought to the mitoribosomal
complex and synthesized into protein. A specific protein of importance in transcription of mitochondrial
DNA is mitochondrial transcription factor A (TFAM). TFAM is one of the two transcription factors that
must be present for mitochondrial transcription to take place (Falkenberg et al., 2002; Tiranti et al.,
1997). TFAM also directly regulates mitochondrial DNA (mt-DNA) copy number in mammals (Ekstrand et
al., 2004). When TFAM was knocked out in mice, mt-DNA copy number decreased. Reduced mt-DNA
copy number results in decreased survival rates and reduced mitochondrial messenger RNA (mt-mRNA)
transcript (H. Li et al., 2000). Two proteins that are specific to the process of mitochondrial translation
are mitochondrial translation initiation factor (mtIF2) and mitochondrial translation elongation factor
(TUFM). mtIF2 is responsible for bringing the fMet-tRNA to the small, 28S subunit of the ribosome and
initiating translation (Liao & Spremulli, 1990). TUFM is responsible for effective and efficient translation
elongation of mt-mRNA transcript (Valente et al., 2007a). In both transcription and translation, TFAM,
mtIF2, and TUFM are crucial to the process of mitochondrial transcription and translation (Smits,
Smeitink, & van den Heuvel, 2010).
The nonpolar, branched-chain amino acid leucine, has been shown to increase the energy
partitioning from adipocytes to muscle cells. This change in energy partitioning or energy usage due to
leucine supplementation has been shown to increase usage of fats in muscle, increased insulin
utilization, improved glucose and cholesterol metabolism, and increased muscle protein synthesis via
the mammalian target of rapamycin(mTOR) pathway (Xu, Kwon, Cruz, Marshall, & McDaniel, 2001; Y.
Zhang et al., 2007).The metabolic enhancements that have been associated with leucine make it a prime
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substrate to be used in studying metabolic syndromes such as obesity. In addition to these findings,
leucine is unique among the other nonpolar, branched chain amino acids, valine and isoleucine, since
leucine is the only one of the three that is sufficient to stimulate muscle protein synthesis, fat utilization,
mitochondrial biogenesis, and decreased protein degradation (Anthony, Anthony, & Layman, 1999;
Liang, Curry, Brown, & Zemel, 2014; Mitch & Clark, 1984). While there is well documented research
showing that leucine has beneficial effects on protein synthesis, its effects on mitochondrial protein
synthesis and biogenesis need to be elucidated (Anthony et al., 1999; Liang et al., 2014). Additionally,
leucine’s effects on these processes in rats on a high fat diet is not understood. Therefore, the purpose
of this study is to determine the effects of leucine supplementation on mitochondrial biogenesis in the
soleus muscle of Sprague-Dawley rats fed a high fat diet. We hypothesize that supplementation with
leucine will attenuate the weight gain of the high fat diet in comparison with the normal chow group, by
enhancing mitochondrial biogenesis and content.
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2. Review of Literature
This review of literature will be separated into five parts discussing leucine supplementation, obesity,
mitochondria, high fat diets, and mitochondrial protein synthesis.
2.1. Leucine
With the rapid rise in obesity, researchers have looked for a substrate that will either nullify or
ameliorate the effects of a high-fat diet. The detrimental metabolic effects of high-diet include increased
skeletal intramuscular triglycerides, mitochondrial dysfunction, and insulin insensitivity. Recently,
however, research into the metabolic effects of the amino acid leucine have shown to increase skeletal
muscle protein synthesis and mitochondrial biogenesis, may be involved in fatty acid mobilization, and
may also increase insulin sensitivity in skeletal muscle(Dodd & Tee, 2012; Liang et al., 2014; Sun &
Zemel, 2007; Xu et al., 2001).
In addition to these effects, leucine also impacts thermogenesis and satiety (Devkota & Layman,
2010). Leucine has been shown to increase thermogenesis, and an increase in thermogenesis necessarily
increases energy expenditure. Additionally, leucine enhances satiety. Satiety, or the feeling of fullness,
can be directly attributed to weight loss. This is to say that a diet containing leucine may have positive
benefits in preventing metabolic syndrome through the enhancement of thermogenesis and satiety
(Devkota & Layman, 2010).
Leucine has been shown to increase skeletal muscle protein synthesis through activation of the
mammalian target of rapamycin (mTOR) pathway. In addition to this function of leucine, it also acts
against the other side of protein turn over by reducing proteolysis. So leucine not only increase muscle
protein synthesis, it also decreases proteolysis(Dodd & Tee, 2012; Paddon-Jones & Rasmussen, 2009) .In
addition to the function of increasing skeletal muscle protein synthesis, leucine has also been shown to
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increase mitochondrial biogenesis (Liang et al., 2014). The specific method of action for increasing
mitochondrial biogenesis is through activation of PGC-1α via sirtuin-1(SIRT-1).
In the past two to three years, interest in the study of SIRT-1 has increased dramatically due to
findings in mouse models that show that SIRT-1 is not only an activator of PGC-1α but also an inhibitor
of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) (Herranz & Serrano, 2010). The
inhibition of NF-κB is important to health specifically in an obese state because it specifically activates
pro-inflammatory cytokines that are associated with obesity (Ganai, Khan, Malik, & Farooqi, 2015).
Leucine has also been shown to increase translation initiation in skeletal muscle of fooddeprived rats. Anthony et al. have shown that leucine, among the other branched-chain amino acids
isoleucine and valine, is a more potent activator of skeletal muscle protein synthesis (Anthony, Anthony,
Kimball, Vary, & Jefferson, 2000). Leucine was shown to act primarily through hyperphosphorylation of
4E-BP1 leading to increased availability of eIF4 to form the active eIF4G-eIF4E complex. Anthony also
showed that in addition to being an activator of translation initiation, leucine also acts through a
rapamycin-sensitive pathway.
Furthermore, leucine has been shown to be of interest for post exercise recovery due to its
ability to increase translation initiation of protein synthesis in skeletal muscle following exercise. This
moves the state of the muscle cell from one that is primarily catabolic during exercise, to one that is of a
positive balance for protein turn over (Norton & Layman, 2006).
2.2. Obesity
In the United States alone, obesity is a major health concern. Studies done at the turn of the
21st century show that nearly 1/3 of the population of adults in the United States are obese (Hedley et
al., 2004). This metabolic syndrome is defined as having a Body Mass Index > 30 kg/m² (World Health
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Organization, 2000).Obesity has many effects on health that include adipose tissue dysfunction, insulin
resistance, mitochondrial dysfunction, basal levels of inflammation, and muscle dysfunction.
a. Economic Concerns Surrounding Obesity
In addition to the health concerns associated with obesity, the cost of healthcare on average for
an obese individual is higher as well. In 1995 the total cost attributable to obesity was $99.2 billion
(Wolf & Colditz, 1998). From this total, $51.64 billion is direct medical cost, and the remaining sum is
due to a combination of lost productivity and lost days of work. In 2001, it was estimated that the
average healthcare costs for an obese individual per year was $1,069 higher than for a normal weight
individual (Wang, Beydoun, Liang, Caballero, & Kumanyika, 2008). Furthermore, in a study spanning
from 1998-2006 estimated that in 2006, obese individuals paid an average of $1,429 more than normal
weight people; therefore, obesity-related healthcare costs were expected to increase total healthcare
cost by $147 billion in 2008 (Finkelstein, Trogdon, Cohen, & Dietz, 2009).
b. Obesity and Health Status
The rising pandemic of obesity is a global health concern. The World Health Organization (WHO)
characterizes obesity as a state of unusual fat mass gathered in adipose tissue, which may cause
extreme health consequences (World Health Organization, 2000). In the United States, obesity is
currently prevalent in nearly two-thirds of the adult population, with an increased prevalence expected.
Research has also shown that obesity is a key predictor of high blood pressure, type 2 diabetes,
cardiovascular disease, and premature death (Ogden et al., 2006).
Body mass index (BMI) is an indirect measure of obesity with a correlation to body fat mass in
children, and adults (World Health Organization, 2000). A BMI value greater than or equal to 30 kg/m² is
considered obese (World Health Organization, 2000). Among adults, a greater proportion of women
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(33.2%) are obese when contrasted with men (31.1%). Complications of obesity in adults include
dyslipidemia, type 2 diabetes, coronary illness, hypertension, and premature death (Weisberg et al.,
2003). Alongside the expansion in rate of obesity in adults, is the increase of obesity in the pediatric
populace. Due to this, the younger generation is experiencing increased levels of type 2 diabetes,
hypertension, cardiovascular ailment, and metabolic syndrome. These elevated comorbidities associated
with obesity have contributed to a decreased quality of life. It has likewise been recognized that when
people struggle with their weight at an early age, they encounter more trouble in losing this weight later
in life.(Ogden et al., 2006).
Obesity has also been shown to prompt insulin and leptin resistance, which brings about
dysfunctional adipose and skeletal tissue (Boyle, Zheng, Anderson, Neufer, & Houmard, 2012). When
this happens, metabolic dysregulation occurs with increased levels of circulating free fatty acids (FFAs),
and increased generation and discharge of pro-inflammatory adipokines (Weisberg et al., 2003). If left
untreated, elevated FFA levels can lead to lipotoxicity, chronic inflammation, hypertension,
atherosclerosis, and cardiovascular disease. An obese individual normally exhibits a debilitated lipid
profile, where triglycerides are raised, high-density lipoprotein (HDL) cholesterol is lessened, and low
density lipoprotein (LDL) is increased (Dyer & Elliott, 1989; Stamler, Stamler, Riedlinger, Algera, &
Roberts, 1978). It is likewise vital to note that visceral fat amassing is more risky for the advancement of
cardiovascular ailment than fat on extremities (Matsuzawa, Nakamura, Shimomura, & Kotani, 1995).
Additionally, there is a link between obesity and advancement of type 2 diabetes with an increased risk
of developing pre-diabetic conditions as an after effect of impeded glucose tolerance, and insulin
resistance in the tissues.
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2.3. Mitochondrial Function
Mitochondria are ubiquitous organelles that are found in aerobic cells (Altmann, 1894). At the
time of their discovery by Altmann, they were called “bioblasts”, and later renamed to be called a
mitochondria. The name “mitochondria” comes from the Greek “mitos” meaning “thread” and
“chondros” meaning “granule.” This renaming was in reference to the appearance of the structure of
the mitochondria during spermatogenesis (Benda, 1898). Altmann hypothesized that the mitochondria
carried out vital functions within the cell but it would not be until almost 50 years later until the
discovery of the mitochondrial role in adenosine triphosphate production (ATP).
Study of the mitochondria began with using redox dyes to observe the staining of mitochondria
using Janus Green B. Janus Green B is a basic dye that is used to supravitally stain mitochondria and
determine oxygen content. It was used by its inventor Leanor Michaelis to stain mitochondria in 1899
(Michaelis, 1899). Following the studies of Michaelis, in 1925 Keilin described the cytochromes as a
series of catalysts that were dehydrogenases (Keilin, 1925). Then, in 1937 the Krebs cycle or citric acid
cycle was discovered and one of the products of this cycle, among others, is nicotinamide adenine
dinucleotide (NADH) (Krebs & Johnson, 1980). NADH is a coenzyme that has either an oxidized (NAD+)
or reduced form (NADH). NADH, the protonated form, is oxidized by the catalytic dehydrogenases that
are the cytochromes (Kennedy & Lehninger, 1949). The importance of this dehydrogenation became
clearer when the superstructure of the mitochondria was determined. In 1952 Palade, using electron
micrographs, ascertained that the mitochondrion is a dual membrane organelle with a rounded outer
membrane and a folded, ridged inner membrane called cristae mitochondriales (Palade, 1952). The
outermost partition between the outer membrane and inner membrane space is called the
intermembrane space and the area within the inner membrane is called the matrix (Racker, 1970). The
structure of the mitochondria in combination with the electron transport chain is then used to create an
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electrochemical gradient between the intermembrane space and the mitochondrial matrix. This
gradient is created by the transport of protons from NADH through the cytochromes, and into the
intermembrane space by the electron transport chain. Then, the electrons move from subunit one
through Q, then to subunit III. After moving from subunit III the electrons move through cytochrome C
and then back into the mitochondrial matrix to form water. This transfer of electrons through the
electron transport chain is used to create the electrochemical and pH gradient between the
intermembrane space and mitochondria matrix. Following electron transport, the energy and proton
motive force generated from the gradient is used to drive ATP synthase and produce ATP (Mitchell,
1966). In addition to ATP, water is also generated through the combination of the proton that moved
through ATP synthase and oxygen.
2.4. Mitochondrial Biogenesis and Content
The molecular mechanisms of mitochondrial biogenesis have only recently been discovered.
Mitochondrial dysfunction is important to discuss in context of mitochondrial biogenesis and is
discussed further in this review of literature. This section is dedicated to current knowledge concerning
the creation and regeneration of mitochondria in the cell.
Mitochondrial biogenesis is defined as the growth and division of already existing mitochondria. It is
of popular scientific belief that the mitochondria originated from an endosymbiotic relationship within a
host cell. The so believed origins of mitochondria come due to the fact that mitochondria replicate by
themselves and contain their own circular genome. From this double stranded, circular, roughly 16.5
kilobase strand, 37 genes are encoded. These 37 genes contribute in the creation of 13 of the subunits
of the electron transport chain that include complexes I, III, IV, and V. In addition to these proteins,
other gene products include 22 tRNAs (transfer RNAs) and two rRNAs (ribosomal RNAs) needed for
translation of the previously mentioned subunits (Baker, Frazier, Gulbis, & Ryan, 2007). Several notable
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ways to induce mitochondrial biogenesis include exercise, caloric restriction, low temperature, oxidative
stress, cell division and renewal and differentiation (Bonnard et al., 2008; Civitarese et al., 2007).
Mitochondrial biogenesis includes both the replication of mitochondria and also the size of
mitochondria.
Important to remember however, is the fact that the majority of proteins that function within the
mitochondria are encoded within the cellular nucleus. This means that the majority of the proteins that
make up the mitochondria come not from its own DNA, but the DNA of the parent cell. These proteins
must pass through specific translocases. There are four major translocases and they include the
translocase of the outer membrane (TOM), translocase of the inner membrane (TIM), presequence
translocase-associated motor (PAM), and sorting and assembly machinery (SAM). TOM is the starting
place for all proteins that pass in and out of the mitochondria, and following TOM, TIM sorts matrix
targeted precursors. Following sorting by TIM, PAM regulates heat shock protein 70(Hsp70) to further
translocation into the matrix. SAM then inserts β-barrel proteins within the bilayer of the outer
membrane. Each of these proteins and their regulatory properties are integral to the success of
mitochondrial biogenesis.
As for signaling cascade mechanisms, there is no known protein of greater importance for the
success and initiation of mitochondrial biogenesis than peroxisome proliferator-activated receptor-γ
(PPAR) coactivator-1 α (PGC-1 α) (Puigserver et al., 1998). Work done by Puigserver et al. in mice
exposed to cold (4 degrees Celsius) induced increased expression of PGC-1 α mRNA expression in tissues
responsible for thermogenesis. Specifically in brown fact and skeletal muscles. The specific function of
PGC-1 α is the co-transcriptional regulation of other transcription factors including nuclear respiratory
factors one and 2(NRF-1 and NRF-2) and transcription factor of activated mitochondria (TFAM). NRF-1
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and NRF-2 are vital in the transcription of mitochondrial enzymes and they work together with TFAM, a
main force in the transcription and replication of mitochondrial DNA (Virbasius & Scarpulla, 1994).
PGC-1β is very similar in molecular structure to PGC-1 α and shares a similar function. It regulates
mitochondrial biogenesis through activation of transcription factors as seen in ectopic expression in L6
myoblasts. PGC-1β also increases basal oxygen consumption. However, the importance between PGC-1
α and PGC-1β is where they differ. Specifically, PGC-1β is not upregulated in brown fat or skeletal muscle
due to cold or due to exercise. Based on this, it appears that PGC-1 α and PGC-1β both contribute to
mitochondrial biogenesis, but they are induced into function through different means (Meirhaeghe et
al., 2003).
2.5. Mitochondrial dysfunction
Mitochondria provide many cells of the body with the ability to produce ATP through aerobic
respiration, regulate intracellular calcium and apoptosis (Green & Reed, 1998; KENNEDY & LEHNINGER,
1949; Sun & Zemel, 2007). It is due to these important functions, that having numerous, healthy
mitochondria are important for health and wellness. Therefore, it is no wonder that there are a growing
number of publications concerning mitochondria in relationship to disease state. Specifically,
mitochondrial dysfunction is associated with obesity and cardiovascular disease (Krieger & Duchen,
2002; Schon & Manfredi, 2003; D. Zhang et al., 2003). Poorly functioning mitochondria manifest
themselves as an increase in overall oxidative stress caused by reactive oxygen species (ROS), and
abnormal values for mitochondrial biomarkers (Murphy, 2009). While there are many biomarkers and
regulatory proteins for mitochondrial health, notable biomarkers that measure mitochondrial biogenesis
and content include PGC-1 α, COX-IV, TFAM, TUFM, and mtif2.
PGC-1α is a major regulatory protein of mitochondrial biogenesis in skeletal muscle. Specifically,
it is a coactivator of PPARγ, an activator of mitochondrial biogenesis (Puigserver et al., 1998). PGC-1 α is
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inducible by exercise training in both rodents and in humans, and expression of PGC-1α increases
oxidative capacity (Baar et al., 2002; Lin, Handschin, & Spiegelman, 2005). PGC-1α knockout mice
fatigue very easily and are unable to complete exercise (Leone et al., 2005).
Cytochrome c oxidase (COX) IV is one of the three enzyme complexes that make up the
structures required for oxidative phosphorylation (Keilin & Hartree, 1939). COX-IV is the oxidative
machinery responsible for the final step of oxidative phosphorylation. In this step, the fourth and final
enzyme in the process takes one proton from each of the other subunits, combines them with oxygen,
and forms water (Y. Li, Park, Deng, & Bai, 2006) .When the protons pass from the intermembrane space
across the electrochemical gradient to combine with oxygen, the energy given off in this process is used
to form ATP from ADP and inorganic phosphate.
Mitochondrial transcription factor A (TFAM) is a marker of mitochondrial protein synthesis.
TFAM is necessary to insure the proper transcription of mitochondrial DNA (Virbasius & Scarpulla, 1994).
This protein biomarker is associated with PGC-1α through the activation of nuclear respiratory factors
one and two (NRF-1 and NRF-2) (Evans & Scarpulla, 1990). It is due to these associations and functions in
the process of mitochondrial DNA transcription that it is commonly used to measure mitochondrial
transcription.
Mitochondrial translation elongation factor (TUFM) has been implicated in studies of
mitochondrial health. TUFM has been shown to be specifically associated with the improper
development of new mitochondrial protein in obese Zucker rats (Greene et al., 2014). Additionally,
TUFM is associated with the insulin cascade and the reduction in insulin sensitivity in a high fat diet
(Matsuzawa-Nagata et al., 2008; Mercader et al., 2012).
Mitochondrial translation initiation factor 2 (mtIF2) is a biomarker associated with TUFM in the
synthesis of mitochondrial DNA. mtIF2 is currently believed to attach to the small subunit of the
15

mitochondrial ribosome and initiate translation. Then, following the attachment of the large subunit to
the small subunit, and GTP hydrolysis, mtIF2 is then released so that elongation can occur (Gaur et al.,
2008).
2.6 Animal Modeling of High-Fat Diets
Obesity and its associated comorbidities such as insulin resistance, dyslipidemia, and type 2
diabetes are important in science and clinical research. In order to study obesity and its associated
metabolic syndromes there must be a suitable, analogous model to study them in animals. The model
must be such that it parallels the pathogenesis of obesity and metabolic syndrome in humans. The
model must also resemble the human phenotype and must be replicable.
Researchers have mainly used two different approaches to metabolic syndrome in animals. On one
side, obesity has been modeled using fa/fa Zucker (obese) and fa/- Zucker (lean) rats. In these rats,
obesity is induced genetically and as such may not be attributable directly to the diet set for them. This
model is mainly used to study the effects of obesity and not the actual process of becoming obese
through a high fat diet.
Another approach to model that has been adopted for the modeling of obesity and metabolic
syndrome is research using high fat diets to induce obesity (Oakes, Cooney, Camilleri, Chisholm, &
Kraegen, 1997). The first research that induced obesity through diet dates back to the 1940s (SAMUELS,
REINECKE, & BALL, 1942). This research used a diet that was %70 fat and is the building block that
modern high fat diet modeling is based off of. And while a diet that is 70% by mass of fat is not
biologically relevant to humans due to the average American fat intake being near 33%, it was a starting
place for the study of high fat diets (National center for health statistics.2014). Samuels et al. showed
that rats fed a high fat diet exhibited abnormal glucose tolerance, and later studies have shown that
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high-fat diets lead to insulin resistance, and hyperglycemia as well. Because of this convention found in
rats, it is accepted that high fat diet feeding can be used to induce and study metabolic syndrome.
2.6. Mitochondrial Protein Synthesis
a. Transcription
In addition to the cellular genome, humans also have unique mitochondrial DNA (mtDNA) that is
separately partitioned within the mitochondria. Mitochondrial DNA is circular, and contains essential
subunits of the electron transport chain and the rRNAs and tRNAs necessary for translation within the
mitochondrial matrix. In order for transcription of mitochondrial DNA to occur, mitochondrial RNA
polymerase(POLRMT) and two transcription factors, mitochondrial transcription factor B2(TFB2M), and
mitochondrial transcription factor A(TFAM) must be present to produce basal levels of RNA
transcription.
POLMRT is responsible for polymerizing ribonucleotides into RNA transcript using DNA as a
template. Mitochondrial RNA polymerases are single subunit structures that are highly similar to the
RNA polymerases found in T3 and T7 bacteriophages (Masters, Stohl, & Clayton, 1987). Like in T7
bacteriophages POLMRT can generate primers to initiate DNA replication, linking both transcription and
replication. The primary mitochondrial transcription initiation factor is TFB2M (Falkenberg et al., 2002).
TFB2M facilitates the change in DNA promotor from closed to open needed for initiation to occur, and
for POLMRT to bind (Litonin et al., 2010). While TFB2M does initiate breakdown of the promotor, it does
not appear to increase binding recognition for POLMRT. In addition to the effects of the promotor
region of DNA, TFB2M also acts on the catalytic site for RNA polymerization (Sologub, Litonin, Anikin,
Mustaev, & Temiakov, 2009).
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TFAM was the first mitochondrial transcription factor identified and is most notable for its ability to
bend and wrap DNA using its High Mobility Group (HMG domains). It is one of the two transcription
factors required for mitochondrial transcription (Litonin et al., 2010). TFAM’s role in transcription
involves binding and bending mtDNA upstream of mtDNA promotors (Fisher & Clayton, 1985). This DNA
bending was later found to be a TFAM imposing a ‘U-turn’ in the DNA promotor where both of the
HMGs turn the DNA 90 degrees (Ngo, Kaiser, & Chan, 2011; Rubio-Cosials et al., 2011). In addition to
DNA bending, TFAM also contributes to transcriptional activation through interaction with TFB2M at its
C-terminal tail, and it is that that the DNA bending imposed by the HMG promotes the TFAM-TFB2M
interaction.
b. Translation
Translation factors are highly conserved proteins that are necessary for successful translation of
mRNA transcript. Bacteria have 3 translation initiation factors Initiation Factors 1-3. Even though
mitochondria are very similar to bacteria in a number of ways, unlike in bacteria, human mitochondria
only require 2(Koc & Spremulli, 2002; Ma, Farwell, Burkhart, & Spremulli, 1995). Those two
mitochondrial translation initiation factors are mtIF2 and mtIF3. It is believed that mtIF2 can replace IF1
through a 37 amino acid insertion and then assume the role of both IF1 and IF2 found in bacteria.(Gaur
et al., 2008). As for the other necessary translation factor in humans, mtIF3, it is involved in initiation of
translation by binding the fMet tRNA and contributes to subunit dissociation (Christian & Spremulli,
2009). Upon successful initiation, mitochondrial translation elongation factor (TUFM) recognizes
properly aminoacylated tRNA molecules and delivers them to the ribosome in a complex with the GTP
necessary for translocation (Hunter & Spremulli, 2004). The interaction is important for the integrity of
the translational process (Nagao, Suzuki, & Suzuki, 2007). The importance of TUFM can be seen in
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studies showing that a single mutation in the TUFM gene can cause infantile encephalopathy from
decreased mitochondrial translation (Valente et al., 2007b).
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3. Specific Aims
Mitochondrial dysfunction occurs specifically in metabolic disease states such as in a high-fat
diet, obesity and diabetes (Chanséaume & Morio, 2009; Mantena et al., 2009). The mitochondria is a
vital structure, and its function is crucial to proper cell signaling, maintenance, and energy metabolism.
The processes involved in mitochondrial regulation and function are numerous, and many of the specific
signaling pathways have yet to be determined. However, it is through these signaling pathways and
protein interactions that mitochondrial function takes place. The transcriptional co-activator peroxisome
proliferator-activated receptor γ co-activator 1 alpha (PGC-1α) is the master regulator of mitochondrial
biogenesis in skeletal muscle (Puigserver et al., 1998; Wu et al., 1999). This protein is highly expressed in
oxidative skeletal muscle such as the soleus muscle, and, in an obese state, PGC-1α expression is lower
than in lean subjects (Greene et al., 2014).
Factors that contribute to regulation of mitochondrial biogenesis and oxidative phosphorylation
include cytochrome c oxidase subunit IV(COX-IV), transcription factor of activated mitochondria (TFAM),
mitochondrial translation initiation factor 2 (mtIF2), and mitochondrial translation elongation factor
(TUFM). COX-IV is a marker of mitochondrial density and has been shown to increase in obese subjects,
it has been hypothesized that this because of impaired autophagy or due to mitochondrial biogenesis
with the former being the current assumption (Greene et al., 2014).TFAM is a transcription factor that
functions in the same pathway as PGC-1α, and is a marker of mitochondrial biogenesis. TFAM is critical
in the process of mitochondrial transcription. mtIF2 and TUFM and both nuclear encoded proteins that
are translated in the cytoplasm and are subsequently translocated into the mitochondria. They are vital
pieces of the process of translation in the mitochondrial matrix, and normal regulation of both mtIF2
and TUFM have been deemed to be necessary for mitochondrial translation (Gaur et al., 2008; Valente
et al., 2007a).
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Aim 1. To examine the effect of leucine supplementation on proteins dealing with mitochondrial
biogenesis in high fat diet fed rats. We hypothesize that a high fat diet supplemented with leucine will
induce increased mitochondrial content and density via elevated PGC1-α and COX IV levels. We will: 1)
Examine the function of leucine on mitochondrial biogenesis through measurement of PGC-1α
expression in high fat diet and control groups; 2) Examine the COX-IV content in the soleus muscle of
each group as a measure of mitochondrial volume between groups: control, control + leucine, high fat,
high fat + leucine.
Aim 2. To examine markers of mitochondrial transcription and translation in rats fed a high fat
diet. We hypothesize that a high fat diet supplemented with leucine will induce transcription and
translation activity via elevated TFAM, mtIF2, and TUFM levels. Experiments will examine the
transcription factors that are co-activated by PGC-1α including TFAM, mtIF2, and TUFM. This will allow
investigators to determine the effect of high fat diets on muscle protein synthesis and where this effect
occurs. We will use Western blotting to measure protein content of TFAM, mtIF2, and TUFM from the
soleus tissue.
We will: 1) Examine mitochondrial transcription by protein expression of TFAM between groups
with normal diets and high fat diets; 2) Examine mitochondrial translation by protein expression of
TUFM and mtIF2 between groups fed a high fat diet and those fed a high fat diet with leucine.
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4. Methods
4.1. Animals used for testing and diet
Eight-week-old male Sprague-Dawley rats (Harlan-Teklad), weighing 220 ± 2.0g at the beginning
of the experiment, were singly housed in a secure, temperature and humidity-controlled environment.
Animals were kept on a 12:12 h reversed light-dark cycle (light 1900 –0700), and were fed commercial
pelleted diet and water ad libitum for 9 days. Once the experiment began, rats were randomly assigned
into treatment groups (n = 4-5/group): 1) control+ glycine; 2) control + leucine; 3) high fat + glycine; 4)
high fat + leucine. Rats were fed macronutrient contents of 60% carbohydrate (CHO), 23.7% protein
(PRO), 15.9% fat (control; Table 2) or 16.9% CHO, 23.4% PRO, 60% fat (HF; Table 2) containing 32 g of
either glycine or leucine per kg of feed. A customized daily feeding schedule as previously reported by
Baum et al. (2006), was used to mimic human eating behavior. Throughout the experimental period, rats
had ad libitum access to water (Baum et al., 2006)(Figure 4A and 4B).
Body mass (BM) and food intake were monitored daily. Before breakfast, rats were placed in a
container on a scale and measurements were recorded in grams (g). Rats were given a set portion of
either a chow diet (4g) or high-fat (3.1g). After 42 days of feeding, rats were sacrificed and tissue was
collected. Soleus muscles were removed and snap-frozen in liquid nitrogen. Samples were stored at 80°C for later analysis.
4.2. Homogenization and Western Blotting
Tissue was homogenized in Mueller Buffer, and protein concentration was measured using the
Qubit 2.0 (LifeTechnologies, Grand Island, NY). Muscle homogenate (30mg/μL) was fractionated into 612% sodium dodecyl sulfate (SDS)-polyacrylamide gels. Gels were transferred over- night to
polyvinylidene difluoride (PVDF) membranes. Membranes were Ponceau stained before blotting to
verify equal loading of the gels. Membranes were blocked in 3-5% bovine serum albumin (BSA), in Tris22

buffered saline with 0.1% Tween-20 (TBST), for 2 h. Primary antibodies for PGC-1α, TUFM, TFAM,
mtIF2, COX-IV (Cell Signaling, Boston, MA, 4850P) were diluted 1:2000–1:8000 in 3-5% BSA or nonfat
milk, in TBST, and incubated at 4°C overnight. Anti-goat, and anti-rabbit secondary antibodies(Santa
Cruz, Santa Cruz, CA) were diluted 1:1,000 in 3-5% BSA or nonfat milk, in TBST, and then incubated at
room temperature for 1 h. Enhanced Chemiluminescence (ECL) was performed using Fluorochem M
imager(Protein Simple, Santa Clara, CA) to visualize antibody- antigen interaction. Blotting images were
quantified by densitometry using AlphaView software (Protein Simple). The Ponceau-stained
membranes were digitally scanned, and the 45-kDa actin bands were quantified by densitometry and
used as a protein loading correction factor for each lane.
4.3. Data Analysis
The independent factors in this study were diet (C vs. HF), and treatment (leucine vs. no
leucine). Dependent variables of interest included protein content of PGC-1α, TFAM, mtIF2, TUFM, and
mitochondrial target protein COX-IV. A diet by treatment (2x2) ANOVA was used to analyze data
regarding each dependent variable of interest. Statistical significance was set with an alpha value of p <
0.05. When significant F ratios are found, a two-tailed Student’s t test post hoc analysis will be used to
distinguish among means. All data will be analyzed using commercial software (SAS, version 9.3, Cary,
NC) and all results will be reported as mean ± SEM.
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5. Results
5.1. Body weight and muscle mass
The rats on a HFD gained significantly more weight (p < .0001) than those fed a normal chow
diet with values of (409.07 ± 3.01 vs. 434. 52 ± 3.01), respectively (Figure 5A).There was a decrease in
the soleus wet weight in NC+Leucine and HF+Leucine groups compared to their respective NC and HF
groups (p<0.05, Figure 5B). Beginning approximately day 20, HF and HF+Leucine rats weighed
significantly more than the NC or NC+Leucine fed rats (p<0.05) for the remainder of the
trial(434.52±3.01 vs. 409.07±3.01) (Figure 5A). Muscle mass to body mass ratios were not significantly
different.
5.2. Expression concerning markers of mitochondrial biogenesis and content
This study used PGC-1 α as a marker of mitochondrial biogenesis in skeletal muscle. There was
no difference in PGC-1 α protein content in the rats supplemented with leucine on the NC diet
compared to rats who were not supplemented. There was a main effect of the HF diet to increase PGC-1
α protein content regardless of leucine supplementation (Figure 5C). This study used COX-IV as a marker
of mitochondrial content in skeletal muscle. There was no effect of leucine supplementation on COX-IV
protein content regardless of leucine supplementation. Diet had no effect on COX-IV protein expression.
(p>0.05)(Figure 5D).
5.3. Protein expression of markers involved in mitochondrial translation and elongation
This study used TUFM as a measure of mitochondrial translation elongation. No differences
were found in the expression of TUFM with regard to leucine supplementation. There was a main effect
of high fat diet to increase expression of TUFM in groups fed a HF diet when compared with those fed a
NC diet (Figure 5E). This study used mtIF2 as a measure of mitochondrial translation initiation in skeletal
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muscle. No significant differences were found in the expression of mtIF2 with regard to leucine
supplementation. There was a main effect of NC diet to increase mtIF2 expression when compared with
those fed a HF diet (p<0.05) (Figure 5F).
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6. Discussion
The goal of this study was to examine the role of leucine supplementation on mitochondrial
biogenesis and biomarkers of mitochondrial transcription and translation on rats fed a high fat diet. It is
important to note that these rats were not in fact obese at the time of testing; they were becoming
obese. However, they were gaining fat mass due to their high fat diet (60% fat). Additionally, the focus
of this study was to determine if leucine would counteract the detrimental effects a high fat diet has on
markers of mitochondrial quantity, biogenesis, and translation. We hypothesized that a high fat diet
supplemented with leucine would yield increased mitochondrial biogenesis and content via PGC-1α and
COX-IV. We also hypothesized that a high fat diet supplemented with leucine would yield increased
mitochondrial transcription and translation via TUFM, and mtIF2.
6.1. Mitochondrial Content and Biogenesis
Peroxisome proliferator-activated receptor-γ coactivator -1α is the “master regulator of
mitochondrial biogenesis (Puigserver et al., 1998). PGC-1α functions through many transcriptional
coactivators, and is a measure of mitochondrial biogenesis. In this study, we found that there was an
increase in PGC-1α expression in the group of rats fed a high fat diet. This is congruent with the
literature in that Greene et al. have found that PGC-1 α protein expression is increased in obese rats
(Greene et al., 2014). It may seem counter intuitive that PGC-1 α would be upregulated in both obese
animals and those fed a high fat diet. PGC-1 α, all expression being normal, should increase the overall
oxidative capacity of the skeletal muscle due to an increase in mitochondrial biogenesis through
activation of transcription pathways (Finck & Kelly, 2006). Increased PGC-1 α is also in line with findings
from Holloway et al. that showed a loss of association between PGC-1α and fatty acid oxidation in obese
humans (Holloway et al., 2008). Additional explanation for this finding can also be due to dysregulation
of PPARδ. PPARδ is a fatty acid sensor and is key in protecting against reduced mitochondrial oxidation
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from fatty acid-induced dysfunction (Ravnskjaer et al., 2010).PGC-1 α was being upregulated in the high
fat diet group, but it is a coactivator of many transcriptional factors including transcription factor of
activated mitochondria(TFAM), nuclear respiratory factors (NRF-1 and NRF-2) and PPARs (Finck & Kelly,
2006; Puigserver & Spiegelman, 2003). Due to PGC-1 α being a coactivator of many other transcription
factors, it may be that there is a decrease in the other ligands such as PPARγ and TFAM in the PGC-1 α
pathway leading to mitochondrial dysregulation. The conclusion therefore is that in this situation, there
are other factors that are at play in regulation of mitochondrial biogenesis other PGC-1 α. While PGC-1 α
is the most important regulator of mitochondrial biogenesis, it appears that there are outside factors as
well.
COX-IV is a measure of mitochondrial content and density. This indicates that the mitochondrial
density of the groups is not significantly different from one another, and that leucine does did not have
an effect on COX-IV expression. This finding does come with some interest though. This study showed
that PGC-1α, a marker of mitochondrial biogenesis, is upregulated with high fat diets. Biogenesis should
necessarily create more mitochondria and increase COX-IV. There may be no change in the expression of
COX-IV at the protein level, but what the mitochondria is doing with this protein is important. During a
high fat diet (60% fat as in this study) Yuzefovych et al. have shown that there is an increase in the
release of COX-IV into the cytosol. This release of COX-IV, a mitochondrial encoded protein, into the
cytosol is indicative of apoptosis. Therefore, the overall measure of COX-IV content is not significantly
different between groups based upon diet or leucine supplementation, but differing regulation of COXIV may be more of an issue than solely expression (Yuzefovych, Musiyenko, Wilson, & Rachek, 2013).
6.2. Mitochondrial Transcription and Translation
Mitochondrial translation elongation factor, or TUFM, aids in elongation after the mRNA
transcript is attached to the ribosome (Smits et al., 2010). This study showed that there was a main
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effect increasing the expression of TUFM in a high fat diet. This finding is consistent with literature
regarding rats fed a high fat diet in another study done by Gutierrez-Aguilar et al. measuring an increase
in the expression of TUFM in skeletal muscle (Gutierrez‐Aguilar, Kim, Woods, & Seeley, 2012). An
additional study from Greene et al. have shown an increase in TUFM mRNA expression in obese animals
as well (Greene et al., 2014). To the current date, TUFM is the main protein involved in regulation of
translation elongation in the mitochondrial genome, and is vital to proper function.
The expression of mitochondrial translation initiation factor (mtIF2) showed no difference with
regard to leucine supplementation. mtIF2’s role is to bring the mRNA transcript to the small subunit of
the ribosome and initiate translation. This study showed that mtIF2 expression was higher in the NC
group when compared with the HF group. In a previous study Davis et al. showed an increase in the
expression of mtIF2 expression with regard to mRNA in high fat diets (Davis et al., 2014).While gene
expression does not always lead to protein expression, this novel finding is one that leads to the
conclusion that there is a dysfunction with regard to the translation of mtIF2 preventing it from being
expressed as in the normal diet group. An increase in mtIF2 mRNA expression in a high fat diet is the cell
signaling for more mtIF2 to be generated. However, this study showed that the relative mtIF2 protein
expression on a high fat diet is less than the expression from that of the NC diet. It is from this that the
conclusion can be drawn that there are other signaling pathways or factors involved in preventing the
mtIF2 mRNA from being translated.
Based on these results, further areas of interest and research can focus on specifically
mitochondrial biogenesis and translation as these areas saw a significant change from the NC group with
regard to diet. While overall it did not appear that leucine had an effect on mitochondrial biogenesis,
content, or translation, there was a trending relationship between it and biogenesis in this study
(.06<p<.065).
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